Soluble CD40 Ligand as a Predictor of Coronary Artery Disease and Long-Term Clinical Outcomes in Stable Patients Undergoing Coronary Angiography | Zendy

Matthew T. Rondina | Zendy; Jason M. Lappé | Zendy; John F. Carlquist | Zendy; Joseph B. Muhlestein | Zendy; Matthew J. Kolek | Zendy; Benjamin D. Horne | Zendy; Robert R. Pearson | Zendy; Jeffrey L. Anderson | Zendy

Open Access

Soluble CD40 Ligand as a Predictor of Coronary Artery Disease and Long-Term Clinical Outcomes in Stable Patients Undergoing Coronary Angiography

Author(s) -

Matthew T. Rondina,

Jason M. Lappé,

John F. Carlquist,

Joseph B. Muhlestein,

Matthew J. Kolek,

Benjamin D. Horne,

Robert R. Pearson,

Jeffrey L. Anderson

Publication year - 2007

Publication title -

cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.547

H-Index - 63

eISSN - 1421-9751

pISSN - 0008-6312

DOI - 10.1159/000106683

Subject(s) - coronary artery disease , medicine , quartile , cardiology , cardiovascular event , cad , odds ratio , acute coronary syndrome , myocardial infarction , confidence interval , engineering drawing , engineering

In patients with acute coronary syndrome (ACS), elevated levels of soluble CD40 ligand (sCD40L) are associated with increased risk of cardiovascular events. We evaluated sCD40L levels and future cardiovascular events in patients not experiencing ACS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research